Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.

39 This study noted a strong trend toward inferior 8-year cause-specific survival (CSS) in Black versus White patients (47.9 v 60.6%; P = .10) with low income ( P = .001) and that the absence of BT ( P = .09) is associated with worse survival in Black patients. 39 A population-based study conducted from the California Cancer Registry included 4,783 patients with CC, of which 45% were treated with BT boost.

also in 5,725 other papers